
Global Flow Cytometry Market
Global Flow Cytometry Market By Segmentation | Flow Cytometry Industry Volume, Value, Trends, Size, Share, Sales, and Key Players Revenue Analysis Report 2021-2026
Published: September 2020 | Report ID:DRR12 | Pages: 150
Flow Cytometry Market Growth, Share and Forecast (2021-2026):
The Global Flow Cytometry Market size is estimated at USD 4.72 billion in 2021 and is projected to reach USD 7.5 billion by 2026 at a CAGR of 10.6% during the forecast period 2021-2026.
Flow Cytometry Market is Segmented by Technology into Cell-based, Bead-based, by Product into Analyzer, Sorter, Reagents, Consumables, Software, by End-User into Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos, by Application into Research Applications, Clinical Applications, Industrial Applications.
Growth in Asia Pacific Region:
According to our research analysis done by the Data Research Reports, the Asia Pacific region is expected to grow at the highest Growth during the assessment year (2021-2026).
Recent Developments in Flow Cytometry Market:
S.No | Year | Recent Development/Acquisition/ Agreements/ Approval |
1 | In June 2019 | Beckman Coulter had Acquired Cytobank |
2 | In Jan 2019 | Luminex Corporation announced the acquisition with Millipore Sigma’s flow cytometry |
3 | In 2018 | Becton Company launched BD FACSymphony S6 high Parmater Cell Sorter
|
Flow Cytometry Market Segmnetation Analysis:
By Technology:
- Cell-based
- Bead-based
By Product:
- Reagents and Consumables
- Instruments
- Cell Analyzers
- High-range
- Mid-range
- Low-range
- Cell Sorters
- High-range
- Mid-range
- Low-range
- Cell Analyzers
- Services
- Software
- Accessories
By Application:
- Research Applications
- Pharmaceuticals and Biotechnology
- Drug Discovery
- Stem Cell Research
- In Vitro Toxicity Testing
- Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
- Pharmaceuticals and Biotechnology
- Clinical Applications
- Cancer Diagnostics
- Hematology
- Immunodeficiency Diseases
- Organ Transplantation
- Other Clinical Applications
- Industrial Applications
By End User:
- Academic & Research Institutes
- Hospitals & Clinical Testing Laboratories
- Pharmaceutical & Biotechnology Companies
Flow Cytometry Market Geographical Analysis:
- North America
- United States
- Canada
- Rest of North America
- Europe
- United Kingdom
- Spain
- Germany
- Italy
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia
- Singapore
- Malaysia
- South Korea
- New Zealand
- Rest of APAC
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of LATAM
- Middle East and Africa
- Middle East
- Africa
Key Players in the Market:
Major Key Players in the Global Flow Cytometry Market are
- Becton, Dickinson and Company
- Beckman Coulter
- Thermo Fisher Scientific
- Merck KGaA
- Luminex Corporation
- Agilent Technologies
- Sony Biotechnology
- Bio-Rad Laboratories
- Miltenyi Biotec
- Enzo Life Sciences, Inc
- Sysmex Partec
- Biomérieux SA
- Cytonome/St, LLC
- Stratedigm, Inc
- Apogee Flow Systems
- Cytek Biosciences, Inc
- Sartorius AG
- Union Biometrica, Inc
- Nanocellect Biomedical, Inc
- On-Chip Biotechnologies Co., Ltd
- Preface
1.1 Market Definition and Scope
1.2 Base Currency, Base Year and Forecast Periods
1.3 Key Research Objectives
1.4 Research Highlights
- General Study Assumptions
- Research Methodology
3.1 Introduction
3.2 Secondary Research
3.3 Primary Research
3.4 Analysis Design
3.5 Study Timeline
- Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Market Trends
- Supply Chain Analysis
- Company Strategy Analysis
6.1 Merger and Acquisition Analysis
6.2 Agreements, Collaborations and Joint Ventures
6.3 Regional Presence
6.4 New Product Launches
- Market Outlook
7.1 Technological Advancement
7.2 Pricing Analysis
7.3 Epidemiology
7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)
- Market Segmentation
8.1 Overview
8.2 Flow Cytometry Market, By Technology, forecast year 2021-2026
8.2.1 Cell-based
8.2.2 Bead-based
8.2.3 Market Size Estimations & Forecasts (2021-2026)
8.2.4 Y-o-Y Growth Analysis
8.2.5 Market Investment Opportunities Analysis
8.3 Flow Cytometry Market, By Product, forecast year 2021-2026
8.3.1 Reagents and Consumables
8.3.2 Instruments
8.3.2.1 Cell Analyzers
8.3.2.1.1 High-range
8.3.2.1.2 Mid-range
8.3.2.1.3 Low-range
8.3.2.2 Cell Sorters
8.3.2.2.1 High-range
8.3.2.2.2 Mid-range
8.3.2.2.3 Low-range
8.3.3 Services
8.3.4 Software
8.3.5 Accessories
8.3.6 Market Size Estimations & Forecasts (2021-2026)
8.3.7 Y-o-Y Growth Analysis
8.3.8 Market Investment Opportunities Analysis
8.4 Flow Cytometry Market, By Application, forecast year 2021-2026
8.4.1 Research Applications
8.4.1.1 Pharmaceuticals and Biotechnology
8.4.1.1.1 Drug Discovery
8.4.1.1.2 Stem Cell Research
8.4.1.1.3 In Vitro Toxicity Testing
8.4.1.2 Immunology
8.4.1.3 Cell Sorting
8.4.1.4 Apoptosis
8.4.1.5 Cell Cycle Analysis
8.4.1.6 Cell Viability
8.4.1.7 Cell Counting
8.4.1.8 Other Research Applications
8.4.2 Clinical Applications
8.4.2.1 Cancer Diagnostics
8.4.2.2 Hematology
8.4.2.3 Immunodeficiency Diseases
8.4.2.4 Organ Transplantation
8.4.2.5 Other Clinical Applications
8.4.3 Industrial Applications
8.4.4 Market Size Estimations & Forecasts (2021-2026)
8.4.5 Y-o-Y Growth Analysis
8.4.6 Market Investment Opportunities Analysis
8.5 Flow Cytometry Market, By End User, forecast year 2021-2026
8.5.1 Academic & Research Institutes
8.5.2 Hospitals & Clinical Testing Laboratories
8.5.3 Pharmaceutical & Biotechnology Companies
8.5.4 Market Size Estimations & Forecasts (2021-2026)
8.5.5 Y-o-Y Growth Analysis
8.5.6 Market Investment Opportunities Analysis
- Global Market Regional and Country Analysis, Forecast 2021-2026
9.1 Overview
9.2 Regional Trends
9.3 Impact Analysis
9.4 Key Findings
9.5 Flow Cytometry Market, by Region, 2021-2026
9.5.1 By Technology
9.5.2 By Product
9.5.3 By Application
9.5.4 By End User
- Competitive Landscape Analysis
10.1 Market Player
10.1.1 Company Revenue
10.1.2 Business unit
10.1.3 Product Mapping
10.1.4 Geographical Locations
10.2 Company Share Analysis
- Strategic Analysis
11.1 PESTLE analysis
11.2 Porter’s Five analysis
11.2.1 Bargaining Power of Suppliers
11.2.2 Bargaining Power of Consumers
11.2.3 Threat of New Entrants
11.2.4 Threat of Substitute Products and Services
11.2.5 Competitive Rivalry within the Industry
- Company Profiles
12.1 Becton, Dickinson and Company
12.1.1 Overview
12.1.2 Product Portfolio
12.1.3 Financial Details
12.1.4 SWOT Analysis
12.1.5 Market Strategies
12.2 Beckman Coulter
12.3 Thermo Fisher Scientific
12.4 Merck KGaA
12.5 Luminex Corporation
12.6 Agilent Technologies
12.7 Sony Biotechnology
12.8 Bio-Rad Laboratories
12.9 Miltenyi Biotec
12.10 Enzo Life Sciences, Inc
12.11 Sysmex Partec
12. 12 Biomérieux SA
12.13 Cytonome/St, LLC
12. 14 Stratedigm, Inc
12. 15 Apogee Flow Systems
12.16 Cytek Biosciences, Inc
12.17 Sartorius AG
12.18 Union Biometrica, Inc
12.19 Nanocellect Biomedical, Inc
12.20 On-Chip Biotechnologies Co., Ltd
- Market Guidance
- Appendix